New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
12:18 EDTT, PRAN, NDZ, TEVA, MNTA, MYL, MUOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday in the last trading day of the first quarter of the year. The disappointing Chicago purchasing managers' report was offset by dovish comments from Fed Chief Yellen, who said the the central bank’s "extraordinary" aid will last for "some time.” ECONOMIC EVENTS: In the U.S., the Chicago PMI business barometer index came in at 55.9, versus the consensus forecast for a 59.0 reading. In Europe, the annual inflation rate across the 18-country eurozone fell for the third consecutive month, slipping to 0.5% in March, compared to analysts' consensus forecast for a milder drop to 0.6%. COMPANY NEWS: Shares of AT&T (T) advanced early in the session after the company's board of directors authorized the repurchase of up to 300M shares, or about 6% of its common shares outstanding. The company also noted it has 125M shares left under its buyback authorization that was issued in March of last year, but the stock had given up much of its early advance to be up fractionally near noon. MAJOR MOVERS: Among the notable gainers was Canada's Nordion (NDZ), which jumped 11% after the company agreed to be acquired by Sterigenics for $11.75 per share in cash shortly after Canada's government lifted its 25% limit on foreign investment in the company. Also higher following analyst commentary was Micron (MU), which rose nearly 8% amid notes in its defense from Stifel and Pacific Crest, as well as broad-based strength in technology stocks that have recently pulled back. Among the noteworthy losers were Momenta Pharmaceuticals (MNTA), which dropped 15%, and Mylan (MYL), which slipped over 1%, after the Supreme Court agreed to hear an appeal by Teva (TEVA) of a court ruling that would enable generic versions of its multiple sclerosis drug, Copaxone, to be sold in May. Also lower were shares of Prana Biotechnology (PRAN), which plunged over 70% after its clinical study of a drug being tested as a treatment of Alzheimer's Disease did not hit its primary endpoint. INDEXES: Near midday, the Dow was up 118.43, or 0.73%, to 16,441.49, the Nasdaq was up 52.48, or 1.26%, to 4,208.23, and the S&P 500 was up 14.56, or 0.78%, to 1,872.18.
News For T;PRAN;NDZ;TEVA;MNTA;MYL;MU From The Last 14 Days
Check below for free stories on T;PRAN;NDZ;TEVA;MNTA;MYL;MU the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
August 25, 2014
11:48 EDTTAT&T, DirecTV agree to deal with DOJ paving way for merger, NY Post says
AT&T (T) has agreed with the Justice Department on terms paving the way for it to acquire DirecTV (DTV), though it could not be learned what, if any, conditions the department has placed on the merger, according to The New York Post, citing a source close to the process. Reference Link
August 22, 2014
10:15 EDTTVodafone rallies amid reports of AT&T takeover bid, FT says
Subscribe for More Information
08:02 EDTMYLMylan launches first generic Klor-Con Extended-release tablets
Subscribe for More Information
07:11 EDTTAT&T may mount bid GBP3 per share bid for Vodafone, Daily Mail reports
AT&T (T) is working on a cash bid worth over GBP3 per share for Vodafone (VOD), according to the Daily Mail. The publication says China Mobile (CHL) may be interested in taking a stake in Vodafone of up to 20%. Reference Link
August 21, 2014
15:16 EDTTEVADEA restricts painkiller drug prescriptions to curb abuse, WSJ reports
The Drug Enforcement Agency, or DEA, will reclassify hydrocodone combination painkiller drugs and place them in the category of medical substances that have the highest potential for harm in an attempt to curb the widespread abuse of the drugs, according to The Wall Street Journal. The rescheduling of the drugs will take effect in 45 days and result in people being able to obtain the drug for only 90 days without obtaining a new prescription. Major manufacturers of these drugs include Teva Pharmaceutical (TEVA), Mallinckrodt (MNK), AbbVie (ABBV), and Actavis (ACT). Reference Link
13:16 EDTTT-Mobile offers free data to users who recruit new customers to its network
T-Mobile (TMUS) is offering its current Simple Choice customers a free unlimited LTE data plan upgrade for a full year when they recruit a Sprint (S), Verizon (VZ), or AT&T (T) customer to its network. The new referred customer will also receive a full year of unlimited LTE data for free as well. If a Simple Choice customer who recruits a new user to T-Mobile's network already has an unlimited LTE data plan, they will receive a $10 credit each month for twelve months. The referral plan starts August 29. Reference Link
11:49 EDTTSprint announces $60 per month unlimited wireless plan
Sprint (S) announces an unlimited wireless plan for $60. The plan provides consumers unlimited talk, text and data while on Sprint's network for $60 per month, a $20 savings compared to T-Mobile's (TMUS) $80 per month unlimited plan, the wireless carrier said. The Sprint $60 Unlimited Plan is available to both new and existing Sprint customers starting tomorrow, August 22. To qualify for the plan, customers must purchase their device through Sprint Easy Pay, pay full retail price or bring their own compatible device.
10:17 EDTMUStocks with call strike movement; MU HTZ
Subscribe for More Information
06:12 EDTMUDRAM prices making downward correction with oversupply concerns, DigiTimes says
Subscribe for More Information
August 20, 2014
11:44 EDTMYLMylan completes second bidding round for GSK prescription portfolio, WSJ says
Mylan (MYL), TPG Capital, Advent International, KKR (KKR), Warburg Pincus and a few Indian prescription manufacturers have completed the second round of bidding for GlaxoSmith Kline's (GSK) portfolio of mature medications, according to The Wall Street Journal, citing people familiar with the sales process. GSK noted that it aims to sell a portfolio of drug brands in the U.S. and EU with yearly sales of approximately $1.66B. Reference Link
11:33 EDTMYLMylan into second round of bidding for GSK drug portfolio, WSJ reports
Subscribe for More Information
August 19, 2014
11:44 EDTMYLMylan launches generic Precedex Injection
Subscribe for More Information
10:01 EDTTAT&T confirms plan to deliver U-verse with AT&T GigaPower in Jacksonville
Subscribe for More Information
07:12 EDTTFCC looks into telecom special access line rates, Reuters says
Subscribe for More Information
06:46 EDTTAT&T technology routes calls to multiple devices, Re/code says
AT&T has developed technology that sends calls from one device to many other devices, Re/code reported yesterday. Reference Link
05:11 EDTTEVAGamida Cell announces investment, option agreement with Novartis
Subscribe for More Information
August 18, 2014
18:33 EDTTSprint introduces Sprint Family Share Pack data plan, doubles high-speed data
Subscribe for More Information
10:06 EDTTEVA, MYLLannett surges after upbeat Q4, FY14 outlook
Subscribe for More Information
08:50 EDTTEVATeva management to meet with JPMorgan
Meeting to be held in Boston on August 20 hosted by JPMorgan.
08:47 EDTTRaymond James to hold a summit
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use